| Barrett Hospital Development Corporation | |
|
30 Mt Highway 91 S Dillon MT 59725-3535 | |
| (406) 683-3000 | |
| (406) 683-3011 |
| Full Name | Barrett Hospital Development Corporation |
|---|---|
| Speciality | General Acute Care Hospital |
| Location | 30 Mt Highway 91 S, Dillon, Montana |
| Authorized Official Name and Position | Richard James Achter (CHIEF FINANCIAL OFFICER) |
| Authorized Official Contact | 4066833003 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Barrett Hospital Development Corporation 600 Mt Highway 91 S Dillon MT 59725-7379 Ph: (406) 683-3000 | Barrett Hospital Development Corporation 30 Mt Highway 91 S Dillon MT 59725-3535 Ph: (406) 683-3000 |
| NPI Number | 1396286480 |
|---|---|
| Provider Enumeration Date | 03/09/2017 |
| Last Update Date | 04/04/2018 |
| Medicare PECOS PAC ID | 4082904487 |
|---|---|
| Medicare Enrollment ID | O20170223001015 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396286480 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | 13549 (Montana) | Secondary |
| 282NC0060X | General Acute Care Hospital - Critical Access | 13549 (Montana) | Primary |
| Provider Name | Burke E Hansen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1821083015 PECOS PAC ID: 0244128072 Enrollment ID: I20040304000997 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | John S Madany |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1487754230 PECOS PAC ID: 3274505458 Enrollment ID: I20040809000708 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Gregory J Moore |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1144315573 PECOS PAC ID: 3971415464 Enrollment ID: I20040914001399 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Sandra A Mcintyre |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083695928 PECOS PAC ID: 8224062054 Enrollment ID: I20050921000859 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Glenn W Mclaughlin |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1447289970 PECOS PAC ID: 3072417427 Enrollment ID: I20070821000353 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Neal M Maxfield |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1366556409 PECOS PAC ID: 0042246761 Enrollment ID: I20070830000071 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Michael S Lifson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1053423798 PECOS PAC ID: 5294824983 Enrollment ID: I20071203000732 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Eric G Lowe |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1164593281 PECOS PAC ID: 5395829410 Enrollment ID: I20080701000392 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Mary D Orourke |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033125091 PECOS PAC ID: 2860564135 Enrollment ID: I20080701000411 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Charlotte R Nelson |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1033395546 PECOS PAC ID: 7911061932 Enrollment ID: I20090205000258 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Jeremy Carlisle |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1437398229 PECOS PAC ID: 4284781659 Enrollment ID: I20090422000368 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Danielle K Beck |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174750285 PECOS PAC ID: 1759435522 Enrollment ID: I20090812000809 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Roy Kohler |
|---|---|
| Provider Type | Practitioner - Sleep Medicine |
| Provider Identifiers | NPI Number: 1215933676 PECOS PAC ID: 0749259042 Enrollment ID: I20100216000752 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Jeremy P Mitchell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770781288 PECOS PAC ID: 9830222736 Enrollment ID: I20100729000011 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Robinette L Jankiewicz |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1275515660 PECOS PAC ID: 9638354640 Enrollment ID: I20110719000798 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Anna S Loge |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306951306 PECOS PAC ID: 0648323485 Enrollment ID: I20110728000122 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Tana Marie Taylor |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1750601423 PECOS PAC ID: 2961527825 Enrollment ID: I20120508000462 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Michelle Lynn Boltz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194843870 PECOS PAC ID: 3274684451 Enrollment ID: I20120803000715 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | David J Crites |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164457453 PECOS PAC ID: 3870678873 Enrollment ID: I20120910000768 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Sarah E Donahue |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699937490 PECOS PAC ID: 8820256977 Enrollment ID: I20120924000206 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Zachary S Sturges |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1992980353 PECOS PAC ID: 7416011267 Enrollment ID: I20130808000277 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Kelly H Smith |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1912137092 PECOS PAC ID: 9133376106 Enrollment ID: I20130911000393 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Tiffany A Kuehl |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1538241096 PECOS PAC ID: 7810988276 Enrollment ID: I20140114001839 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Jean A Hamilton |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1184656191 PECOS PAC ID: 3476535113 Enrollment ID: I20140515001413 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Patrick C Rasch |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1699064667 PECOS PAC ID: 5395988216 Enrollment ID: I20140929001021 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Scott Rigdon |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1134371503 PECOS PAC ID: 6901965482 Enrollment ID: I20150109000724 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Marybeth L Wilson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1144515263 PECOS PAC ID: 5193040731 Enrollment ID: I20150203000001 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Maura Davenport |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1972896074 PECOS PAC ID: 4486970092 Enrollment ID: I20150225002212 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Tara M Thompson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1891167946 PECOS PAC ID: 9436459617 Enrollment ID: I20151119000413 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Michael E Clarke |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1497983142 PECOS PAC ID: 9032361738 Enrollment ID: I20151123001218 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Tyler Hurst |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1699110932 PECOS PAC ID: 2860704673 Enrollment ID: I20160606000465 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Seth E Wiley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407206170 PECOS PAC ID: 9638463151 Enrollment ID: I20160805002070 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Denis E Jones |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1528092152 PECOS PAC ID: 9931160827 Enrollment ID: I20160830002998 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Jared Phelps |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1700293354 PECOS PAC ID: 8426351263 Enrollment ID: I20170817004062 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Camilla E Juhl-petersen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1073809232 PECOS PAC ID: 2769637768 Enrollment ID: I20171107001581 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Stacy Regan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1912155698 PECOS PAC ID: 7618284845 Enrollment ID: I20180109001276 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Daniel T Richards |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1649455403 PECOS PAC ID: 5193899607 Enrollment ID: I20180619003250 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Kelly J Dewey |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1952656183 PECOS PAC ID: 5597063354 Enrollment ID: I20181012002380 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Colin C Brockett |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1548680721 PECOS PAC ID: 8628297132 Enrollment ID: I20190326000251 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Thomas J Schumacher |
|---|---|
| Provider Type | Practitioner - Other (non-physician) |
| Provider Identifiers | NPI Number: 1942328711 PECOS PAC ID: 0042402703 Enrollment ID: I20190429002667 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Kenny Joe Wallen |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1649628553 PECOS PAC ID: 4183916182 Enrollment ID: I20190730003670 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Trevor Thorpe |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1710482740 PECOS PAC ID: 0143583575 Enrollment ID: I20200106000167 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Amy E Wellborn |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1205226149 PECOS PAC ID: 7517393960 Enrollment ID: I20200204001299 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Tracy M Roberts |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396384301 PECOS PAC ID: 9739515800 Enrollment ID: I20200208000176 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Elizabeth Ann Church |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013519008 PECOS PAC ID: 6507278116 Enrollment ID: I20201223000620 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Cody Moore |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1720547862 PECOS PAC ID: 7214333285 Enrollment ID: I20220707000798 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Jared Scott Jones |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1316409477 PECOS PAC ID: 6507191806 Enrollment ID: I20220720002939 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Robert Redwood |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1639457740 PECOS PAC ID: 7416181508 Enrollment ID: I20221115002066 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Stephen Perry |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1356689418 PECOS PAC ID: 3577700095 Enrollment ID: I20221121003353 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Emily G Martin |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1518381417 PECOS PAC ID: 1355698531 Enrollment ID: I20230119002892 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Jessica Simmons |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1447671755 PECOS PAC ID: 3476784752 Enrollment ID: I20230320002454 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Matthew Maunu |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1881684546 PECOS PAC ID: 7214079037 Enrollment ID: I20230420000723 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Carolyn Hansen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295223493 PECOS PAC ID: 1557618907 Enrollment ID: I20230503002490 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Debra J Young |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1730267956 PECOS PAC ID: 9234295296 Enrollment ID: I20230503002937 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Kathleen Maunu |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1548251911 PECOS PAC ID: 6103881172 Enrollment ID: I20230808001876 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Devin Holt |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1073036174 PECOS PAC ID: 8325310568 Enrollment ID: I20230907001330 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Ashley Kollodge |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1932739224 PECOS PAC ID: 9537595384 Enrollment ID: I20231213001237 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
| Provider Name | Michael J Zappas |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1013191568 PECOS PAC ID: 7618002924 Enrollment ID: I20240112000417 |
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
News Archive
Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.
Researchers at Oregon State University have developed two new modified toy car designs for children with disabilities in an effort to encourage them to further explore, play, and engage in physical and social activities.
SANImagenetix, Inc. announced today results for the three months ended June 30, 2010. Net sales decreased 36% for the first quarter of fiscal year 2011 to $1,085,000 from $1,702,000 for the same period of last year. Net loss for the first quarter was $604,000 or $.05 per share compared to a loss of $415,000 or $.04 per share for the same period of the prior fiscal year.
Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
› Verified 5 days ago
Beaverhead Urgent Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 120 S Atlantic St, Dillon, MT 59725 Phone: 406-683-4400 Fax: 406-683-4408 | |
Blacktail Dental Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 125 E Glendale St, Dillon, MT 59725 Phone: 406-683-4440 Fax: 406-683-1121 | |
Sweet Medicine Therapy Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 435 S Atlantic St, Suite 104, Dillon, MT 59725 Phone: 406-683-4453 Fax: 406-683-4453 | |
Patricia A Grantham M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 Mt Highway 91 S Ste 205, Dillon, MT 59725 Phone: 406-683-4252 | |
C Curtis Blake M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 Mt Highway 91 S Ste 206, Dillon, MT 59725 Phone: 406-683-4252 | |
Burke E Hansen M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 Mt Highway 91 S Ste 204, Dillon, MT 59725 Phone: 406-683-4252 |